Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ray Balyeat (NPI 1376538769)

Field	Value
Entity Type	Individual
Organization	Ray Balyeat
Address	2000 S Wheeling Ave
City	Tulsa
State	OK
ZIP	74104
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 13, 2005

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

Provider-level payer mix is effectively single-payer: the provider reports Total Medicare revenue of $2.1M and has no Medicaid billing on file, so Medicaid does not contribute to this practice's recorded revenue. This profile indicates the provider's Medicare business drives the full observable billing footprint.

Service-line mix is concentrated in intravitreal biologic therapy and associated injection procedures: the top revenue codes are J2777 and J0178 (biologic intravitreal injections) alongside 67028 (intravitreal injection procedure), and the code descriptions indicate routine administration of anti-VEGF and newer retinal biologic agents. This pattern is consistent with a retina-focused ophthalmology practice that generates revenue primarily from high-volume injectable therapies rather than from surgery or predominantly office-based evaluation.

Revenue concentration is high: the top three Medicare codes by revenue account for 86.2% of this provider's total Medicare revenue, with J2777 reported as $920.5K revenue (43.5% of this provider's total Medicare revenue), J0178 reported as $790.3K revenue (37.3% of this provider's total Medicare revenue), and 67028 reported as $115.1K revenue (5.4% of this provider's total Medicare revenue). This concentration shows most Medicare dollars flow from two high-cost injectable drugs plus the separate injection procedure.

Clinical volume mix favors procedures and imaging over evaluation-and-management revenue: 99213 generated $36.1K (1.7% of total Medicare revenue) while procedure- and imaging-related codes such as 92014 produced $94.6K (4.5%) and 92134 produced $42.4K (2.0%). The relatively small share from E/M codes compared with drug and injection codes indicates a practice model where encounters are often driven by procedural drug administration and retina imaging rather than extended E/M visits.

Competitive standing by code varies but is not consistently dominant: J2777 is reported at 31.7K claims and $920.5K revenue and “ranks #267 of 2039 providers nationally (87th percentile; typical, unremarkable volume for this code),” while J0178 at 1.2K claims and $790.3K revenue “ranks #1131 of 3204 providers nationally (65th percentile; typical, unremarkable volume for this code).” In contrast, routine retina service codes show higher-than-typical national volume—92014 “ranks #1270 of 35415 providers nationally (96th percentile; notably above typical national volume for this code)” and 92134 “ranks #1441 of 26868 providers nationally (95th percentile; notably above typical national volume for this code)”—suggesting steady clinic throughput for imaging and follow-up visits.

There are selective low-volume or ancillary service signals consistent with occasional alternative therapies and diagnostics: J7312 (dexamethasone implant) shows $18.9K revenue and “ranks #462 of 492 providers nationally (5th percentile; typical, unremarkable volume for this code),” and J9035 (bevacizumab) shows $1.1K revenue and “ranks #1800 of 1852 providers nationally (2th percentile; typical, unremarkable volume for this code).” These placements imply infrequent use of some implants or off-label agents relative to national peers rather than anomalous behavior.

Tenure and stability: the provider's NPI was enumerated on 2005-09-13 (~21 years ago), indicating long-standing enrollment in Medicare. Combined with the concentrated injection-based revenue mix, this tenure supports an interpretation of an established retinal injection practice with sustained Medicare activity over many years.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	31,740	$30	$920.5K
J0178	Injection, aflibercept, 1 mg	1,150	$690	$790.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,350	$90	$115.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,130	$80	$94.6K
J2778	Injection, ranibizumab, 0.1 mg	330	$180	$58.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,570	$30	$42.4K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	670	$50	$36.1K
J7999	Compounded drug, not otherwise classified	340	$60	$21.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	120	$160	$18.9K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	270	$20	$6.5K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Ray Balyeat — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	11	30	790	$690	$801.2K
J2777	6	20	23,040	$30	$781.1K
J2778	6	10	420	$180	$173.2K
67028	15	40	720	$80	$88.9K
J7312	4	10	340	$150	$54.8K
J9035	31	30	330	$50	$23.5K
92235	18	20	60	$100	$19.5K
99214	3,936	5,560	130	$70	$18.4K
92014	16	550	130	$70	$16.6K
J7999	3	20	170	$70	$14.5K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ray Balyeat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Walter Peters	OK	Ophthalmology Physician	$405.1K	$0
Jamal Siddiqui	OK	Ophthalmology Physician	$368.3K	$0
Marc Goldberg	OK	Ophthalmology Physician	$297.1K	$0
Madeleine Hasbrook	MI	Ophthalmology Physician	$206.1K	$0
Todd Brockman	OK	Ophthalmology Physician	$184.5K	$0
Neha Sangal	OK	Ophthalmology Physician	$183.7K	$220
Daniel Corbett	OK	Cornea and External Diseases Specialist Physician	$168.5K	$0
Shannon Cox	OK	Ophthalmic Plastic and Reconstructive Surgery Physician	$164.6K	$0

Nearby Providers

Other providers in the same ZIP code as Ray Balyeat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Green Country Emergency Physicians Group Of Tulsa PLLC	OK	Emergency Medicine Physician	$0	$18.9M
St. John Physicians, Inc.	OK	Internal Medicine Physician	$0	$17.7M
Ahs Oklahoma Physician Group LLC	OK	Family Medicine Physician	$0	$17.4M
Ahs Hillcrest Medical Center, LLC	OK	General Acute Care Hospital	$0	$14.4M
Osu Center For Health Sciences	OK	Medical Specialty Clinic/Center	$0	$8.5M
Oklahoma State University	OK	Medical Specialty Clinic/Center	$0	$8.2M
Mbc Dental	OK	General Practice Dentistry	$0	$7.4M
Osu Center For Health Sciences	OK	Clinic/Center	$0	$6.4M
Community Health Connection, Inc.	OK	Federally Qualified Health Center (FQHC)	$0	$6.4M
Tulsa Hospitalists Inc	OK	Internal Medicine Physician	$0	$5.6M

Ray Balyeat — Billing Profile & Reimbursement Data

Sign up for Ray Balyeat — Billing Profile & Reimbursement Data policy alerts

Ray Balyeat — Billing Profile & Reimbursement Data

Sign up for Ray Balyeat — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References